We identified a novel AGO2/miR-185-3p/NRP1 regulatory axis that modulates EMT and the metastatic capability of CRC cells, which might represent a regulatory process for cancer cell migration and metastasis in general (Fig. 6L). The gene discussed is AGO2; the disease is cancer.